Home
News & Analysis

News & Analysis

The sword, the shield, the olive branch – NuCurrent’s path to IP value creation

In an exclusive interview, the company’s CEO Jacob Babcock details its journey to becoming a technology licensing business

A new wave of US biosimilar patent disputes begins

After a lull in biologic versus imitator disputes, Regeneron has sued Mylan and more litigation is likely to follow

The patent challenges of the Indian company set to become the world’s biggest biosimilars business

In an exclusive interview Biocon Biologics’ chief IP counsel explains the issues that he and his team focus on – and how an upcoming, big-ticket merger will lead to change

Latest content

Why the UK Apple/Optis dispute is a must-watch for SEP strategists

The country’s third ever FRAND trial decision will build on the global licensing approach laid out in Unwired Planet

12 July 2022

Court analytics show Zebra’s $360M settlement with Honeywell follows litigation track record

The outcome was unsurprising considering Zebra’s settlements in other litigation, though a newly announced licence with InterDigital proves the company also comes to the negotiation table

11 July 2022

Ericsson SEP decision sees 5G iPhones banned in the Colombian market

Apple hit with blow in first decision of SEP/FRAND dispute with Swedish company

11 July 2022

Pure Storage’s patent team reveals strategy; how REATISS responded when Ukraine was invaded; Nokia wins German SEP injunction; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

10 July 2022

Patentees must accept eligibility quagmire and plan accordingly

Since US Supreme Court justices declined to review American Axle, patent law must still share a box with Schrodinger’s Cat

09 July 2022

Toyota and Honda ramp up patent filings as wireless technologies become litigation battlefield

London-based firm Mathys & Squire’s research reveals that Japan is the most popular patenting jurisdiction for auto OEMs

08 July 2022

Lessons from China's $46 billion IP financing market

After over a decade and the involvement of various stakeholders, China achieved $46 billion in IP financing in 2021

08 July 2022

Covid-19 patent wars spread to Europe as CureVac sues BioNTech

German mRNA innovators poised for fight over vaccine revenues in the Dusseldorf Regional Court

08 July 2022

The top design and trademark filers at the EUIPO revealed

L'Oréal was the leading corporate applicant for EU trademarks across 12 months, according to office data

07 July 2022

Detecting AI patent infringement

Co-published – There is often an assumption that reverse engineering of machine learning models is not possible, however that does not need to be the case

07 July 2022

Get unlimited access to all IAM content